Commercial code

Technicolor Creative Studios: Combined General Shareholders’ Meeting held on May 15, 2023

Retrieved on: 
Monday, May 15, 2023
Parc du 26e Centenaire, Bank statement, Meeting Ground Theatre Company, Urban, Commercial code, Chairperson, Euronext Paris, PIMCO, Combined, Angelo Gordon, Annual general meeting, Id Tech 6, Holding company, Management, Security (finance), Life insurance

Combined General Shareholders’ Meeting held on May 15, 2023

Key Points: 
  • Combined General Shareholders’ Meeting held on May 15, 2023
    Paris (France), May 15, 2023 - Technicolor Creative Studios (Euronext Paris: TCHCS) (the "Company") announces that the Combined General Shareholders’ Meeting (the “Meeting”), chaired by Ms. Anne Bouverot, Chairperson of the Board of Directors, was held today at 2pm at the Urban Station-Espace du Centenaire, 189 rue de Bercy, 75012 Paris.
  • The company's shareholders have been strongly mobilized for this Meeting, which gathered a quorum of 81.72 %.
  • The Board of Directors of the Company, which met at the close of this Meeting, sincerely thanks all shareholders for their support.
  • The Board of Directors, which met after the Meeting, appointed Mrs. Cécile Davies as observer representing Pimco.

EQS-News: Dolkam Suja a.s.: CONVOCATION OF ORDINARY GENERAL MEETING

Retrieved on: 
Wednesday, May 3, 2023
MTV Europe Music Award for Best Czech & Slovak Act, Exercise, CC, Companies Act 2006, Internet, Coll, XI, Self-publishing, Para, Article, Rajec, ID, Person, AOA, District court, Publishing, Art, Risk, Block B, Chinese Foreign Permanent Resident ID Card, OGM, Bratislava, Proxy, SB, Commercial code, Security (finance), Holding company

Shareholder has the right to participate in and vote at general meeting.

Key Points: 
  • Shareholder has the right to participate in and vote at general meeting.
  • A shareholder attends the general meeting personally or represented by proxy holder based on a written proxy pursuant to Sec.
  • Template of the written proxy which can be used for proxy voting is attached to this convocation.
  • 190a CC nor the shareholders’ participation in and voting at the general meeting by electronic means pursuant to Sec.

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023

Retrieved on: 
Wednesday, May 3, 2023
Biotechnology, Pharmaceutical, Genetics, Health, Exercise, Balo language, Annual, Mass meeting, Commercial code, Annual general meeting, Combined, Email, Bulletin, Security (finance), Audit

In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.

Key Points: 
  • In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.
  • For any questions relating to the Annual General Meeting of May 24, 2023, shareholders are invited to send an email to [email protected] .
  • The conditions for holding and taking part in this Combined Shareholders’ General Meeting may evolve depending on the health, regulatory and legal requirements in place.
  • In general, shareholders are invited to regularly consult the section dedicated to the General Meeting on the Company's website www.sensorion.com .

EQS-News: Formycon publishes results for financial year 2022

Retrieved on: 
Friday, April 28, 2023
GMP, Trademark, Partnership, International, Half-life, KG, MedImmune, Inc. v. Genentech, Inc., FYB, European Medicines Agency, COVID-19, Tax, EBIT, Genentech, Esselte Leitz GmbH & Co KG, Gesellschaft mit beschränkter Haftung, EMA, EBITDA, Acquisition, Regeneron Pharmaceuticals, Investment, Patient, Ophthalmology, ISIN, United Kingdom, Depreciation, Biosimilar, Development, HGB, FDA, Pembrolizumab, Annual report, Ustekinumab, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Commercial code, Security (finance), Chemical, Cryptocurrency, Generic drug, Fine chemical, Pharmaceutical industry, Euro

The annual report at Group level is published for the first time in accordance with IFRS (International Financial Reporting Standards).

Key Points: 
  • The annual report at Group level is published for the first time in accordance with IFRS (International Financial Reporting Standards).
  • Furthermore, a toxicity study has been initiated, which results are a prerequisite for entering the clinical development phase.
  • On December 31, 2022, the Formycon Group's financial figures had developed as follows: Group revenues, which in addition to Formycon AG also include the fully consolidated subsidiaries Formycon Project 201 GmbH, FYB202 Project GmbH, Formycon Project 203 GmbH, Bioeq GmbH and the 50% stake in Bioeq AG increased to a total of Euro 42.5 million (2021 IFRS: Euro 36.6 million) in the fiscal year 2022.
  • Formycon AG achieved revenues (HGB) of Euro 28.3 million in the financial year 2022 (2021 HGB: Euro 26.5 million).

Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq

Retrieved on: 
Wednesday, April 26, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Madison Avenue, Code, European Parliament, ADS, European, Telephone, SEC Rule 144A, Annual, Jefferies, Regulation D, EDGAR, Sale, US, ATM, Euronext Paris, Jefferies Group, Prospectus, IPH, IPHA, Council, Form, Security (finance), Commercial code, Annual general meeting, Property management, Shareholder, EU, Innate Immunotherapeutics

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it has filed a prospectus supplement with the Securities and Exchange Commission (“SEC”) relating to a new At-The-Market (“ATM”) program.

Key Points: 
  • Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it has filed a prospectus supplement with the Securities and Exchange Commission (“SEC”) relating to a new At-The-Market (“ATM”) program.
  • The ATM program is presently intended to be effective unless terminated in accordance with the sales agreement or the maximum amount of the program has been reached.
  • In connection with the establishment of a new ATM program, the Company has terminated the sales agreement, dated as of May 3, 2022, relating to its previous ATM program, effective as of April 19, 2023.
  • During the 2023 Annual General Meeting, new resolutions allowing for capital increases will be put to the shareholders’ vote.

EQS-News: action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards

Retrieved on: 
Wednesday, April 26, 2023
WKN, Bank statement, Tax, AG, Frankfurt, Gesellschaft mit beschränkter Haftung, Acquisition, Earnings before interest, taxes, depreciation and amortization, ISIN, HGB, News, Commercial code, Security (finance), Cryptocurrency

action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards

Key Points: 
  • action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards
    The issuer is solely responsible for the content of this announcement.
  • This was primarily due to profit transfers and group allocations with the two subsidiaries action press international GmbH and ddp media GmbH.
  • As much as 2022 went as expected, the synergy effects of the reorganization are having an impact: so far, fiscal 2023 has been profitable.
  • With around 160 million photos (as of October 2022), action press is one of the largest image databases in the world.

Technicolor Creative Studios: Conditions of availability of information prepared in connection with the Combined Shareholders’ Meeting to be held May 15, 2023

Retrieved on: 
Sunday, April 23, 2023
Exercise, Combined, Commercial code, Property management

Conditions of availability of information prepared in connection with the Combined Shareholders’ Meeting to be held May 15, 2023

Key Points: 
  • Conditions of availability of information prepared in connection with the Combined Shareholders’ Meeting to be held May 15, 2023
    Shareholders are invited to participate to the Combined Shareholders’ Meeting to be held on:
    The Preliminary Notice of Meeting (avis préalable de réunion), including agenda and proposed resolutions was published in the French Bulletin des annonces légales obligatoires (BALO) on April 7, 2023 and a Notice of Meeting (avis de convocation) will be published at the latest on April 28, 2023 in a legal announcement support and in the French Bulletin des annonces légales obligatoires (BALO).
  • The documents referred to in article R. 225-83 of the French Commercial Code are made available to shareholders as of this date, in accordance with applicable regulations:
    any shareholder holding registered shares may request that the Company sends these documents at no charge, up to and including the fifth day prior to the Meeting (for shareholders holding bearer shares, the exercise of this right is subject to the submission of a certificate of participation issued by their financial institution);
    any shareholder may consult these documents at the Company’s registered office, up to the fifteenth day prior to the Meeting.
  • Documents referred to in article R. 22-10-23 of the French Commercial Code may be consulted on the Company’s website: www.technicolorcreative.com .

COMBINED SHAREHOLDERS’ MEETING TO BE HELD ON MAY 25, 2023 - AVAILABILITY OF THE DOCUMENTS RELATING TO THE 2023 COMBINED SHAREHOLDERS’ MEETING

Retrieved on: 
Wednesday, April 19, 2023
Combined, Mass meeting, Commercial code, Proxy, Bulletin, Holding company, Security (finance), Financial services

Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms.

Key Points: 
  • Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms.
  • Holders of registered shares will receive these forms with their convening notice.
  • Information relating to this Meeting may be consulted on SCOR’s website at www.scor.com under the “Investors/Shareholders’ Meetings” section.
  • The shareholders’ Meeting will be broadcasted live on the Company's Internet site: www.scor.com

EQS-News: Cantourage Group SE: Strong revenue growth in 2022 and Q1 2023 based on preliminary figures

Retrieved on: 
Saturday, April 15, 2023
Bank statement, Dronabinol, Pharmacist, Patient, ISIN, Cannabis, SE, HGB, Commercial code, Drug

Berlin, 14 April 2023 – Cantourage Group SE (hereafter “Cantourage”, ISIN: DE000A3DSV01), a leading European producer and distributer of cannabis-based medicinal products, generated revenues of approximately EUR 14 million* in the 2022 fiscal year (2021: EUR 5.2 million), on the basis of preliminary and unaudited figures.

Key Points: 
  • Berlin, 14 April 2023 – Cantourage Group SE (hereafter “Cantourage”, ISIN: DE000A3DSV01), a leading European producer and distributer of cannabis-based medicinal products, generated revenues of approximately EUR 14 million* in the 2022 fiscal year (2021: EUR 5.2 million), on the basis of preliminary and unaudited figures.
  • Furthermore, also based on preliminary figures, Cantourage increased revenues in Q1 2023 by more than 95 % year-on-year.
  • Cantourage forms partnerships with cannabis cultivators worldwide, imports their cannabis flowers and processes them into medicinal products in Germany.
  • The pro forma financial information shows a hypothetical consolidation of the Cantourage Group and future financial information may differ from the pro forma information.

EQS-News: H&R GmbH & Co. KGaA confirms preliminary figures and publishes Annual Report 2022

Retrieved on: 
Saturday, April 15, 2023
Annual, EUR, HGB, EBITDA, Frankfurt Stock Exchange, Annual report, Publication, Bank statement, Commercial code, Fine chemical

H&R GmbH & Co. KGaA has achieved distributable earnings in accordance with the German Commercial Code (HGB) for 2022.

Key Points: 
  • H&R GmbH & Co. KGaA has achieved distributable earnings in accordance with the German Commercial Code (HGB) for 2022.
  • The management will propose to the Annual General Meeting to distribute a dividend of EUR 0.10 per share.
  • For a complete presentation of the business development including the segment reporting and the annual financial statements, H&R KGaA refers to the Annual Report 2022, which is published today at www.hur.com - Investors - Publications.
  • H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment.